Search

everythinglearnresearchcommunity

for

Search:↓

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Finasteride may lower cholesterol and slow heart disease progression.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

More precise, personalized therapies are needed for autoimmune diseases.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

TREM2 macrophages and unsaturated lipids contribute to acne inflammation.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Alopecia mucinosa can be treated successfully with minocycline.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.